Table 3 Changes from baseline to 6-month visit in SGLT2 patients
Baseline | 6-month | Δ from baseline | p | |
|---|---|---|---|---|
Indexed LVM (g/m2) | 98.5 ± 27.9 | 87.6 ± 18.4 | − 10.8 ± 3.3 | 0.003 |
LV end-diastolic volume (ml) | 103.3 ± 40.0 | 100.8 ± 34.0 | − 2.5 ± 5.0 | 0.62 |
LV end-diastolic diameter (mm) | 46.9 ± 5.0 | 45.7 ± 4.3 | − 1.2 ± 0.67 | 0.09 |
LV ejection fraction (%) | 62.9 ± 8.2 | 62.6 ± 8.4 | − 0.4 ± 1.5 | 0.81 |
RWT | 0.47 ± 0.07 | 0.46 ± 0.06 | − 0.01 ± 0.01 | 0.44 |
GLS | − 17.8 ± 2.9 | − 19.1 ± 3.1 | 1.29 ± 0.47 | 0.01 |
LA indexed volume (ml/m2) | 31.9 ± 9.8 | 31.2 ± 9.9 | − 0.75 ± 1.28 | 0.56 |
E/A ratio | 0.81 ± 0.39 | 0.92 ± 0.52 | 0.10 ± 0.05 | 0.07 |
Lateral e’ (cm/s) | 8.31 ± 2.19 | 9.07 ± 2.57 | 0.76 ± 0.47 | 0.12 |
Septal e’ (cm/s) | 5.91 ± 1.37 | 6.57 ± 1.60 | 0.66 ± 0.25 | 0.01 |
E/e’ ratio | 10.5 ± 3.6 | 10.0 ± 3.9 | − 0.52 ± 0.53 | 0.34 |